Here are some of the latest health and medical news
developments, compiled by the editors of HealthDay:
Motrin Infants Formula Recalled
About 200,000 bottles of Motrin Infants formula, which is used
to treat fever and aches and pains in children 2 years old and
younger, are being recalled because they may contain tiny plastic
particles, Johnson & Johnson says.
The recall covers three lots of Motrin Infants' Drops Original
Berry Flavor. The lot numbers of the recalled half-ounce bottles
are DCB3T01, DDB4R01 and DDB4S01, the
The recalled products may contain tiny bits of PTFE, which is a
plastic used in Teflon coatings. It's unclear if the recalled
bottles actually contain the particles, which were found in a
different product during the manufacturing process, J&J's
McNeil unit said, the news service reported.
Both products contain the same shipment of ibuprofen from a
third-party supplier, the company explained.
"From our perspective, during the manufacturing process at the third party supplier, that's when the particles got into the ibuprofen," McNeil Vice President Ed Kuffner told the AP. He would not identify the supplier that made the ibuprofen.
No illnesses or injuries associated with the affected medicine
have been reported to date, according to the company.
McNeil has told retailers to remove the recalled lots from their
shelves. Consumers should stop using the products and call McNeil
for a refund at 1-877-414-7709, the
Drug Cocktail Protects Monkeys Against MERS: Study
A combination of two antiviral drugs protected monkeys against
the deadly Middle East Respiratory Syndrome coronavirus (MERS) and
could potentially be used to save people infected with the virus, a
new study says.
Researchers at the U.S. National Institute of Allergy and
Infectious Diseases gave ribavirin and interferon to three of six
rhesus monkeys eight hours after they were infected with MERS,
The New York Timesreported.
The three monkeys that received the drug cocktail had lower
levels of virus in their blood, no breathing problems and only
minimal X-ray evidence of pneumonia, while the untreated monkeys
became severely ill, according to the study in the journal
The findings are "not a game changer, but an important
observation," according to institute director Dr. Anthony Fauci,
He noted that it was a small study, treatment started soon after
the monkeys were infected, and that drugs that are effective in
monkeys sometimes fail in humans. However, Fauci added that "if I
were a doctor with MERS patients, and I had nothing else to give
them, I wouldn't hesitate. If someone has advanced disease, there's
50 percent mortality."
Most of the MERS cases have occurred in Saudi Arabia. Doctors
there have already tried this two-drug combination on patients, but
it did not work well, Dr. Ziad Memish, Saudi Arabia's deputy health
minister, told the
However, this may have been because the drug treatment was
started late, when patients were hospitalized and already very ill,
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.